158 related articles for article (PubMed ID: 10982775)
1. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis.
Thomas LA; Veysey MJ; Bathgate T; King A; French G; Smeeton NC; Murphy GM; Dowling RH
Gastroenterology; 2000 Sep; 119(3):806-15. PubMed ID: 10982775
[TBL] [Abstract][Full Text] [Related]
2. Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly.
Thomas LA; Veysey MJ; Murphy GM; Russell-Jones D; French GL; Wass JA; Dowling RH
Gut; 2005 May; 54(5):630-5. PubMed ID: 15831907
[TBL] [Abstract][Full Text] [Related]
3. Review: pathogenesis of gallstones.
Dowling RH
Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():39-47. PubMed ID: 10903002
[TBL] [Abstract][Full Text] [Related]
4. Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples.
Thomas LA; Veysey MJ; French G; Hylemon PB; Murphy GM; Dowling RH
Gut; 2001 Dec; 49(6):835-42. PubMed ID: 11709519
[TBL] [Abstract][Full Text] [Related]
5. Role of intestinal transit in the pathogenesis of gallbladder stones.
Dowling RH; Veysey MJ; Pereira SP; Hussaini SH; Thomas LA; Wass JA; Murphy GM
Can J Gastroenterol; 1997; 11(1):57-64. PubMed ID: 9113801
[TBL] [Abstract][Full Text] [Related]
6. Influence of pH on the phase distribution of nascent deoxycholic acid in fresh human cecal aspirates.
Thomas LA; Veysey MJ; Murphy GM; Dowling RH
Am J Physiol Gastrointest Liver Physiol; 2001 Aug; 281(2):G371-4. PubMed ID: 11447017
[TBL] [Abstract][Full Text] [Related]
7. Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.
Veysey MJ; Thomas LA; Mallet AI; Jenkins PJ; Besser GM; Wass JA; Murphy GM; Dowling RH
Gut; 1999 May; 44(5):675-81. PubMed ID: 10205204
[TBL] [Abstract][Full Text] [Related]
8. Colonic transit influences deoxycholic acid kinetics.
Veysey MJ; Thomas LA; Mallet AI; Jenkins PJ; Besser GM; Murphy GM; Dowling RH
Gastroenterology; 2001 Oct; 121(4):812-22. PubMed ID: 11606495
[TBL] [Abstract][Full Text] [Related]
9. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.
Azzaroli F; Mazzella G; Mazzeo C; Simoni P; Festi D; Colecchia A; Montagnani M; Martino C; Villanova N; Roda A; Roda E
Am J Gastroenterol; 1999 Sep; 94(9):2453-9. PubMed ID: 10484008
[TBL] [Abstract][Full Text] [Related]
10. 7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones.
Berr F; Kullak-Ublick GA; Paumgartner G; Münzing W; Hylemon PB
Gastroenterology; 1996 Dec; 111(6):1611-20. PubMed ID: 8942741
[TBL] [Abstract][Full Text] [Related]
11. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
[TBL] [Abstract][Full Text] [Related]
12. Cholylglycine hydrolase and 7alpha-dehydroxylase optimum assay conditions in vitro and caecal enzyme activities ex vivo.
Thomas LA; King A; French GL; Murphy GM; Dowling RH
Clin Chim Acta; 1997 Dec; 268(1-2):61-72. PubMed ID: 9495571
[TBL] [Abstract][Full Text] [Related]
13. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
[TBL] [Abstract][Full Text] [Related]
14. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors.
Marcus SN; Heaton KW
Gut; 1986 May; 27(5):550-8. PubMed ID: 3699564
[TBL] [Abstract][Full Text] [Related]
15. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile.
Hussaini SH; Pereira SP; Murphy GM; Dowling RH
Hepatology; 1995 Dec; 22(6):1735-44. PubMed ID: 7489982
[TBL] [Abstract][Full Text] [Related]
16. Deoxycholic acid is not related to lithogenic factors in gallbladder bile.
Jüngst D; Müller I; Kullak-Ublick GA; Meyer G; Frimberger E; Fischer S
J Lab Clin Med; 1999 Apr; 133(4):370-7. PubMed ID: 10218768
[TBL] [Abstract][Full Text] [Related]
17. The metabolic consequences of slow colonic transit.
Lewis SJ; Heaton KW
Am J Gastroenterol; 1999 Aug; 94(8):2010-6. PubMed ID: 10445521
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
Einarsson C; Hillebrant CG; Axelson M
Hepatology; 2001 May; 33(5):1189-93. PubMed ID: 11343248
[TBL] [Abstract][Full Text] [Related]
19. Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel.
Xu QW; Scott RB; Tan DT; Shaffer EA
Hepatology; 1996 Jun; 23(6):1664-72. PubMed ID: 8675191
[TBL] [Abstract][Full Text] [Related]
20. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.
Veysey MJ; Malcolm P; Mallet AI; Jenkins PJ; Besser GM; Murphy GM; Dowling RH
Gut; 2001 Dec; 49(6):828-34. PubMed ID: 11709518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
